Clinical Trial Update: Efficacy of Pregabalin in Migraine Prevention [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pregabalin for migraine prevention was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Hospital Militar del General Luis Felipe Brieba Aran | Conditions: Migraine Disorders | Phase 3 | Status: WITHDRAWN